NO880297L - Fremgangsmaate for fremstilling av 6-beta (substituert)-(s)-hydroksymetylpenicillansyrer og derivater derav. - Google Patents

Fremgangsmaate for fremstilling av 6-beta (substituert)-(s)-hydroksymetylpenicillansyrer og derivater derav.

Info

Publication number
NO880297L
NO880297L NO880297A NO880297A NO880297L NO 880297 L NO880297 L NO 880297L NO 880297 A NO880297 A NO 880297A NO 880297 A NO880297 A NO 880297A NO 880297 L NO880297 L NO 880297L
Authority
NO
Norway
Prior art keywords
penicillan
hydroxymethyl
beta
derivatives
acids
Prior art date
Application number
NO880297A
Other languages
English (en)
Other versions
NO172493C (no
NO172493B (no
NO880297D0 (no
Inventor
Yuhpyng Liang Chen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO880297D0 publication Critical patent/NO880297D0/no
Publication of NO880297L publication Critical patent/NO880297L/no
Publication of NO172493B publication Critical patent/NO172493B/no
Publication of NO172493C publication Critical patent/NO172493C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO880297A 1987-01-27 1988-01-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-beta (substituert)-(s)-hydroksymetylpenicillansyrer og derivater derav NO172493C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US731987A 1987-01-27 1987-01-27

Publications (4)

Publication Number Publication Date
NO880297D0 NO880297D0 (no) 1988-01-25
NO880297L true NO880297L (no) 1988-07-28
NO172493B NO172493B (no) 1993-04-19
NO172493C NO172493C (no) 1993-07-28

Family

ID=21725481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880297A NO172493C (no) 1987-01-27 1988-01-25 Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-beta (substituert)-(s)-hydroksymetylpenicillansyrer og derivater derav

Country Status (25)

Country Link
EP (1) EP0276942B1 (no)
JP (1) JPS63246384A (no)
KR (1) KR900005050B1 (no)
CN (1) CN1014710B (no)
AT (1) ATE74359T1 (no)
AU (2) AU590142B2 (no)
CA (1) CA1288091C (no)
DD (1) DD279882A5 (no)
DE (1) DE3869630D1 (no)
DK (1) DK36788A (no)
ES (1) ES2031589T3 (no)
FI (1) FI880334A (no)
GR (1) GR3004460T3 (no)
HU (1) HU205765B (no)
IE (1) IE60348B1 (no)
IL (1) IL85167A (no)
MY (1) MY102312A (no)
NO (1) NO172493C (no)
NZ (1) NZ223296A (no)
PH (1) PH24478A (no)
PL (2) PL159842B1 (no)
PT (1) PT86613B (no)
SU (2) SU1591812A3 (no)
YU (2) YU46436B (no)
ZA (1) ZA88514B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0276942B1 (en) * 1987-01-27 1992-04-01 Pfizer Inc. 6-beta(substituted)-(s)-hydroxymethylpenicillanic acids and derivatives thereof
AU5617398A (en) * 1996-12-30 1998-07-31 Beacon Laboratories L.L.C. Tricarboxylic acid-containing oxyalkyl esters and uses thereof
GB0128052D0 (en) * 2001-11-22 2002-01-16 Drug Discovery Lab As Compounds
US8187727B2 (en) 2005-07-22 2012-05-29 Lg Chem, Ltd. Imidazole derivatives, preparation method thereof and organic electronic device using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4272439A (en) * 1978-06-02 1981-06-09 Schering Corporation 6-(Substituted-hydroxymethylene penams)
US4304779A (en) * 1979-05-09 1981-12-08 Schering Corporation 6-(Nitrogen-containing heterocyclic)hydroxymethylpenicillanic acids, compounds related thereto and processes for their preparation
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
GR77151B (no) * 1982-01-11 1984-09-07 Prizer
DD234015A5 (de) * 1984-01-30 1986-03-19 Pfizer Verfahren zur herstellung von 6-(subst.)-methylen-penicillan-und 6-(subst.)-hydroxymethyl-penicillansaeure und deren derivaten
EP0150984B1 (en) * 1984-01-30 1991-09-11 Pfizer Inc. 6-(substituted) methylenepenicillanic and 6-(substituted) hydroxymethylpenicillanic acids and derivatives thereof
EP0276942B1 (en) * 1987-01-27 1992-04-01 Pfizer Inc. 6-beta(substituted)-(s)-hydroxymethylpenicillanic acids and derivatives thereof

Also Published As

Publication number Publication date
YU14488A (en) 1990-02-28
MY102312A (en) 1992-05-28
PH24478A (en) 1990-07-18
PL159842B1 (pl) 1993-01-29
EP0276942B1 (en) 1992-04-01
KR880009030A (ko) 1988-09-13
HU205765B (en) 1992-06-29
AU1074388A (en) 1988-07-28
IL85167A0 (en) 1988-07-31
FI880334A0 (fi) 1988-01-26
PL161601B1 (pl) 1993-07-30
GR3004460T3 (no) 1993-03-31
PT86613B (pt) 1991-12-31
FI880334A (fi) 1988-07-28
ES2031589T3 (es) 1992-12-16
IE60348B1 (en) 1994-06-29
DK36788A (da) 1988-09-23
SU1681730A3 (ru) 1991-09-30
AU4883290A (en) 1990-05-17
CN88100588A (zh) 1988-08-10
PT86613A (pt) 1988-02-01
NZ223296A (en) 1989-10-27
ATE74359T1 (de) 1992-04-15
NO172493C (no) 1993-07-28
YU46436B (sh) 1993-10-20
HUT47118A (en) 1989-01-30
EP0276942A1 (en) 1988-08-03
CN1014710B (zh) 1991-11-13
YU124389A (en) 1990-12-31
CA1288091C (en) 1991-08-27
NO172493B (no) 1993-04-19
NO880297D0 (no) 1988-01-25
YU47020B (sh) 1994-11-15
DD279882A5 (de) 1990-06-20
DE3869630D1 (de) 1992-05-07
JPS63246384A (ja) 1988-10-13
DK36788D0 (da) 1988-01-26
IL85167A (en) 1994-01-25
IE880197L (en) 1988-07-27
KR900005050B1 (en) 1990-07-19
PL270301A1 (en) 1988-12-08
SU1591812A3 (ru) 1990-09-07
AU613821B2 (en) 1991-08-08
AU590142B2 (en) 1989-10-26
ZA88514B (en) 1989-09-27

Similar Documents

Publication Publication Date Title
LU90159I2 (fr) Difloxacin optionnellement sous forme d'un sel ou ester pharmaceutique
EP0422596A3 (en) Tricyclic carbapenem compounds
LTIP1916A (en) Cephalosporin derivatives with antibacterial activity
AU2044697A (en) Phenylalkylcarboxylic acid derivatives
DE3170437D1 (en) 2-oxoazetidine derivatives, their production and use
NO880297D0 (no) Fremgangsmaate for fremstilling av 6-beta (substituert)-(s)-hydroksymetylpenicillansyrer og derivater derav.
DE3876712D1 (de) Antianaerobe naphthyridinverbindungen.
ATE111468T1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und antibakterielle mittel.